fluticasone furoate

Known as: Furoate de fluticasone, Furoato de fluticasona, fluticasone furoate [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Chronic obstructive pulmonary disease (COPD) often coexists with cardiovascular disease. Treatments for airflow… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND The short-term benefits of inhaled corticosteroids for patients with chronic obstructive pulmonary disease (COPD) are… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
RATIONALE Radiographically confirmed pneumonia risk with inhaled corticosteroid use in chronic obstructive pulmonary disease… (More)
Is this relevant?
2014
2014
The inhaled corticosteroid fluticasone furoate (FF) and the long-acting β₂ agonist vilanterol (VI) are in development as a… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Whether the combination of a once-daily inhaled corticosteroid with a once-daily longacting β(2) agonist is more… (More)
Is this relevant?
2013
2013
BACKGROUND Once-daily combination treatment is an attractive maintenance therapy for COPD. However, the dose of inhaled… (More)
Is this relevant?
2011
2011
Currently available glucocorticoids are relatively short acting and may be less effective in patients with chronic obstructive… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Fluticasone furoate (USAN-approved name) is a novel, enhanced-affinity glucocorticoid administered in a unique side… (More)
Is this relevant?
2007
2007
BACKGROUND Fluticasone furoate (drug code GW685698) is an enhanced-affinity glucocorticoid that has been developed for the… (More)
Is this relevant?
2007
2007
BACKGROUND Fluticasone furoate is a new enhanced-affinity glucocorticoid with a unique combination of pharmacodynamic and… (More)
Is this relevant?